Global Fibrin Sealants Market 2019-2023 - Product Image

Global Fibrin Sealants Market 2019-2023

  • ID: 4662754
  • Report
  • Region: Global
  • 106 pages
  • TechNavio
OFF
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • Baxter
  • CSL
  • Ethicon
  • Pharmaceutical
  • Takeda
  • MORE
About Fibrin Sealants

Fibrin sealants is a two-component substance, namely thrombin and fibrinogen that are used to control bleeding during surgical procedures.

The analysts forecast the Global Fibrin Sealants Market to grow at a CAGR of 8.09% during the period 2019-2023.

Covered in this report
The report covers the present scenario and the growth prospects of the fibrin sealants market. To calculate the market size, the report considers the revenue generated by the sale of fibrin sealant products across the globe.

The market is divided into the following segments based on geography:
  • Americas
  • APAC
  • EMEA
The report, fibrin sealants market 2019-2023, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Baxter
  • CSL
  • Ethicon
  • Takeda Pharmaceutical
Market drivers
  • Increasing number of surgical procedures
  • For a full, detailed list, view the full report
Market challenges
  • High cost of fibrin sealants
  • For a full, detailed list, view the full report
Market trends
  • Strong clinical trial pipeline
  • For a full, detailed list, view the full report
Key questions answered in this report
  • What will the market size be in 2023 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the Key vendors?
  • What are the strengths and weaknesses of the key vendors?
You can request one free hour of the analyst’s time when you purchase this market report. Details are provided within the report.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Baxter
  • CSL
  • Ethicon
  • Pharmaceutical
  • Takeda
  • MORE
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: MARKET LANDSCAPE
  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
PART 04: MARKET SIZING
  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
PART 06: MARKET SEGMENTATION BY PRODUCT
  • Market segmentation by product
  • Comparison by product
  • Patches - Market size and forecast 2018-2023
  • Liquid - Market size and forecast 2018-2023
  • Others - Market size and forecast 2018-2023
  • Market opportunity by product
PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE
  • Geographic segmentation
  • Geographic comparison
  • Americas - Market size and forecast 2018-2023
  • EMEA - Market size and forecast 2018-2023
  • APAC - Market size and forecast 2018-2023
  • Market opportunity
PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES
  • Market drivers
  • Market challenges
  • Market challenges
PART 11: MARKET TRENDS
  • Strong clinical trial pipeline
  • Adoption of minimally invasive and robotic surgeries
  • Competitive business strategy
PART 12: VENDOR LANDSCAPE
  • Overview
  • Landscape disruption
PART 13: VENDOR ANALYSIS
  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Baxter
  • CSL
  • Ethicon
  • Takeda Pharmaceutical
PART 14: APPENDIX
  • Research methodology
  • List of abbreviations
PART 15: About the Author


List of Exhibits
Exhibit 01: Global medical devices market
Exhibit 02: Segments of global medical devices market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Market size 2018
Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 09: Five forces analysis 2018
Exhibit 10: Five forces analysis 2023
Exhibit 11: Bargaining power of buyers
Exhibit 12: Bargaining power of suppliers
Exhibit 13: Threat of new entrants
Exhibit 14: Threat of substitutes
Exhibit 15: Threat of rivalry
Exhibit 16: Market condition - Five forces 2018
Exhibit 17: Product - Market share 2018-2023 (%)
Exhibit 18: Comparison by product
Exhibit 19: Patches - Market size and forecast 2018-2023 ($ millions)
Exhibit 20: Patches - Year-over-year growth 2019-2023 (%)
Exhibit 21: Liquid - Market size and forecast 2018-2023 ($ millions)
Exhibit 22: Liquid - Year-over-year growth 2019-2023 (%)
Exhibit 23: Others - Market size and forecast 2018-2023 ($ millions)
Exhibit 24: Others - Year-over-year growth 2019-2023 (%)
Exhibit 25: Market opportunity by product
Exhibit 26: Customer landscape
Exhibit 27: Market share by geography 2018-2023 (%)
Exhibit 28: Geographic comparison
Exhibit 29: New applications of fibrin sealants at the University of Virginia, US
Exhibit 30: Americas - Market size and forecast 2018-2023 ($ millions)
Exhibit 31: Americas - Year-over-year growth 2019-2023 (%)
Exhibit 32: Top 3 countries in Americas
Exhibit 33: EMEA - Market size and forecast 2018-2023 ($ millions)
Exhibit 34: EMEA - Year-over-year growth 2019-2023 (%)
Exhibit 35: Top 3 countries in EMEA
Exhibit 36: APAC - Market size and forecast 2018-2023 ($ millions)
Exhibit 37: APAC - Year-over-year growth 2019-2023 (%)
Exhibit 38: Top 3 countries in APAC
Exhibit 39: Country_Legend_3
Exhibit 40: Market opportunity
Exhibit 41: Appendectomy surgeries in European hospitals (per 100,000 inhabitants) in 2015
Exhibit 42: Product launch by companies
Exhibit 43: Average cost of fibrin sealants
Exhibit 44: Impact of drivers and challenges
Exhibit 45: Vendor landscape
Exhibit 46: Landscape disruption
Exhibit 47: Vendors covered
Exhibit 48: Vendor classification
Exhibit 49: Market positioning of vendors
Exhibit 50: Baxter - Vendor overview
Exhibit 51: Baxter - Business segments
Exhibit 52: Baxter - Organizational developments
Exhibit 53: Baxter– Geographic focus
Exhibit 54: Baxter - Segment focus
Exhibit 55: Baxter – Key offerings
Exhibit 56: Baxter - Key customers
Exhibit 57: CSL - Vendor overview
Exhibit 58: CSL - Business segments
Exhibit 59: CSL - Organizational developments
Exhibit 60: CSL – Geographic focus
Exhibit 61: CSL - Segment focus
Exhibit 62: CSL - Key offerings
Exhibit 63: CSL - Key customers
Exhibit 64: Ethicon - Vendor overview
Exhibit 65: Ethicon - Product segments
Exhibit 66: Ethicon - Organizational developments
Exhibit 67: Ethicon - Segment focus
Exhibit 68: Ethicon - Key offerings
Exhibit 69: Ethicon - Key customers
Exhibit 70: Takeda Pharmaceutical - Vendor overview
Exhibit 71: Takeda Pharmaceutical - Organizational developments
Exhibit 72: Takeda Pharmaceutical – Geographic focus
Exhibit 73: Takeda Pharmaceutical - Key offerings
Exhibit 74: Takeda Pharmaceutical - Key customers
Exhibit 75: Validation techniques employed for market sizing
Exhibit 76: List of abbreviations
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Baxter
  • CSL
  • Ethicon
  • Pharmaceutical
  • Takeda
  • MORE
Global Fibrin Sealants Market 2019-2023

The author of the report recognizes the following companies as the key players in the global fibrin sealants market: Baxter, CSL, Ethicon, and Takeda Pharmaceutical.

Commenting on the report, an analyst from the research team said: “One trend affecting this market is the strong clinical trial pipeline. The number of products under clinical trial pipeline waiting for clearance from respective regulatory authorities in some countries is high. This will result in the launch of novel fibrin sealants during the forecast period.”

According to the report, one driver influencing this market is the driven by the increasing number of surgical procedures. Fibrin sealants industry growth is expected to accelerate massively over the next five years driven by the increase in chronic conditions that have resulted in the rise of surgical procedures across the globe.

Further, the report states that one challenge affecting this market is the high cost of fibrin sealants. Fibrin sealants are found to be very effective to control bleeding, however their high cost is hindering the growth of the global fibrin sealant market.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
  • Baxter
  • CSL
  • Ethicon
  • Takeda
  • Pharmaceutical
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll